BeOne Medicines (BEIGF) Preferred Stock Liabilities (2015)
BeOne Medicines (BEIGF) reported Preferred Stock Liabilities of $176.1 million for Q4 2015.
BeOne Medicines (BEIGF) Preferred Stock Liabilities (2015) Analysis & Trends
BeOne Medicines (BEIGF) has 1 years of Preferred Stock Liabilities data on file, last reported at $176.1 million in Q4 2015.
- Preferred Stock Liabilities for Q4 2015 came in at $176.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $176.1 million (changed N/A YoY), and the FY2015 annual result was $176.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $176.1 million in Q4 2015 per BEIGF's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $176.1 million in Q4 2015 and troughed at $176.1 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 176.08 Mn |